GLP1R and Insulin resistance: It upregulates glucagon‐like peptide‐1 receptor (GLP‐1R) expression in the pancreas (Wang et al. 2020), inhibits caspase family proteins and AIF (Liang et al. 2019), promoting β‐cell proliferation, preventing β‐cell apoptosis, increasing serum insulin levels, alleviating insulin resistance, and reducing fasting blood glucose.